Serum levels of adiponectin are reduced in obese individuals, and inversely correlate with several diseases, including type II diabetes [1], cardiovascular diseases [2] and metabolic syndromes [3], as well as the risk of developing multiple types of cancers [4]. This evidence concerns the gene ADIPOQ and cancer.